HQ Function

Served as the primary center for research and development, manufacturing of its UBM-based products, and corporate operations, including sales, marketing, and administrative functions.

Notable Features:

The facility likely housed advanced laboratories for tissue processing, biomaterials research, and cleanroom manufacturing environments essential for medical device production.

Work Culture:

As a biotech company in the regenerative medicine space, the work culture was likely characterized by innovation, scientific rigor, a strong focus on research and development, and a mission-driven approach to improving patient outcomes. Collaboration between scientific, clinical, and commercial teams would have been crucial.

HQ Significance:

The Columbia, MD headquarters was central to ACell's development and commercialization of its proprietary MatriStem UBM™ technology, establishing its presence in the regenerative medicine market before its strategic acquisition.

Values Reflected in HQ: The headquarters would have reflected ACell's commitment to scientific innovation, quality manufacturing, and addressing unmet medical needs through regenerative therapies.

Location:

Prior to its acquisition by Integra LifeSciences, ACell, Inc.'s primary market was the United States. While they may have had some international distribution or regulatory approvals in select countries, their main operational focus, including sales, marketing, clinical support, and R&D, was heavily concentrated in the US. Post-acquisition, the former ACell products are part of Integra LifeSciences' global distribution network.

Street Address:

6640 Eli Whitney Dr

City:

Columbia

State/Province:

Maryland

Country:

USA